» Articles » PMID: 25119599

MiR-152 Suppresses Gastric Cancer Cell Proliferation and Motility by Targeting CD151

Overview
Journal Tumour Biol
Publisher Sage Publications
Specialty Oncology
Date 2014 Aug 15
PMID 25119599
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

We aimed to study the post-translational regulation of CD151 by the microRNA miR-152. CD151 is highly expressed in gastric cancer (GC) and has been shown to accelerate GC by enhancing invasion and metastasis; however, its regulation is still unclear. Our results showed decreased expression of miR-152 in GC tissue samples and cell lines. In addition, miR-152 complementation significantly inhibits both the proliferation and motility of GC cells. CD151 was found to be a target of miR-152, and overexpression of CD151 attenuated the suppressive effect of miR-152. Our findings highlight an essential role of miR-152 in the regulation of proliferation and motility of GC cells and suggest a potential application of miR-152 in GC treatment.

Citing Articles

Tetraspanins in digestive‑system cancers: Expression, function and therapeutic potential (Review).

Chen K, Li Q, Li Y, Jiang D, Chen L, Jiang J Mol Med Rep. 2024; 30(5).

PMID: 39239742 PMC: 11411235. DOI: 10.3892/mmr.2024.13324.


The members of the miR-148/152 family inhibit cancer stem cell-like properties in gastric cancer via negative regulation of ITGA5.

Li X, Li L, Wu J J Transl Med. 2023; 21(1):105.

PMID: 36765401 PMC: 9912648. DOI: 10.1186/s12967-023-03894-1.


Long noncoding RNA (lncRNA) HOTAIR: Pathogenic roles and therapeutic opportunities in gastric cancer.

Kong W, Yin G, Zheng S, Liu X, Zhu A, Yu P Genes Dis. 2022; 9(5):1269-1280.

PMID: 35873034 PMC: 9293693. DOI: 10.1016/j.gendis.2021.07.006.


The association between polymorphism of the long noncoding RNA, Plasmacytoma variant translocation 1, and the risk of gastric cancer.

Park J, Jin E, Hong J, Lee S, Sung J Medicine (Baltimore). 2022; 100(48):e27773.

PMID: 35049170 PMC: 9191314. DOI: 10.1097/MD.0000000000027773.


Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer.

Xu J, Wen J, Li S, Shen X, You T, Huang Y Front Genet. 2021; 12:690598.

PMID: 34290743 PMC: 8287335. DOI: 10.3389/fgene.2021.690598.


References
1.
Chen J, Yao D, Li Y, Chen H, He C, Ding N . Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma. Int J Mol Med. 2013; 32(3):557-67. PMC: 3782554. DOI: 10.3892/ijmm.2013.1424. View

2.
Zoller M . Gastrointestinal tumors: metastasis and tetraspanins. Z Gastroenterol. 2006; 44(7):573-86. DOI: 10.1055/s-2006-926795. View

3.
Zhang N, Wei X, Xu L . miR-150 promotes the proliferation of lung cancer cells by targeting P53. FEBS Lett. 2013; 587(15):2346-51. DOI: 10.1016/j.febslet.2013.05.059. View

4.
Ayaz L, Gorur A, Yaroglu H, Ozcan C, Tamer L . Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol. 2013; 139(9):1499-506. DOI: 10.1007/s00432-013-1469-2. View

5.
Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90. DOI: 10.3322/caac.20107. View